VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 66 filers reported holding VINCERX PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,071 | -20.1% | 24,822 | +2.8% | 0.00% | – |
| Q2 2023 | $31,387 | +25.0% | 24,144 | 0.0% | 0.00% | – |
| Q1 2023 | $25,110 | +8.4% | 24,144 | +6.3% | 0.00% | – |
| Q4 2022 | $23,159 | -54.6% | 22,705 | -37.8% | 0.00% | – |
| Q3 2022 | $51,000 | -26.1% | 36,525 | -28.8% | 0.00% | – |
| Q2 2022 | $69,000 | -47.3% | 51,268 | +57.5% | 0.00% | – |
| Q1 2022 | $131,000 | -58.3% | 32,556 | +5.6% | 0.00% | – |
| Q4 2021 | $314,000 | -44.1% | 30,833 | -11.3% | 0.00% | – |
| Q3 2021 | $562,000 | +34.1% | 34,751 | +7.6% | 0.00% | – |
| Q2 2021 | $419,000 | +87.1% | 32,311 | +177.2% | 0.00% | – |
| Q1 2021 | $224,000 | +409.1% | 11,657 | +450.1% | 0.00% | – |
| Q4 2020 | $44,000 | – | 2,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |